SEC Info - Johnson & Johnson - ‘8-K’ for 4/20/21

SEC Info℠

Home

Help

Please Sign In

Johnson & Johnson – ‘8-K’ for 4/20/21

On: Tuesday, 4/20/21, at 8:02am ET · For: 4/20/21 · Accession #: 200406-21-24 · File #: 1-03215

  As Of               Filer                 Filing    For·On·As Docs:Size

 4/20/21  Johnson & Johnson                 8-K:2,9     4/20/21   14:1.1M

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     31K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     37K 
 3: EX-99.2     Miscellaneous Exhibit                               HTML    231K 
10: R1          Cover                                               HTML     61K 
12: XML         IDEA XML File -- Filing Summary                      XML     13K 
 9: XML         XBRL Instance -- jnj-20210420_htm                    XML     40K 
11: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 5: EX-101.CAL  XBRL Calculations -- jnj-20210420_cal                XML      7K 
 6: EX-101.DEF  XBRL Definitions -- jnj-20210420_def                 XML     45K 
 7: EX-101.LAB  XBRL Labels -- jnj-20210420_lab                      XML     97K 
 8: EX-101.PRE  XBRL Presentations -- jnj-20210420_pre               XML     46K 
 4: EX-101.SCH  XBRL Schema -- jnj-20210420                          XSD     15K 
13: JSON        XBRL Instance as JSON Data -- MetaLinks               15±    22K 
14: ZIP         XBRL Zipped Folder -- 0000200406-21-000024-xbrl      Zip     45K

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C: C:

jnj-20210420

i 0000200406 i false00002004062021-04-202021-04-200000200406us-gaap:CommonStockMember2021-04-202021-04-200000200406jnj:A0.250NotesDue2022Member2021-04-202021-04-200000200406jnj:A0.650NotesDue2024Member2021-04-202021-04-200000200406jnj:A5.50NotesDue2024Member2021-04-202021-04-200000200406jnj:A1.150NotesDue2028Member2021-04-202021-04-200000200406jnj:A1.650NotesDue2035Member2021-04-202021-04-20

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM i 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The

Securities Exchange Act of 1934

Date of report (Date of earliest event reported):

i April 20, 2021

i Johnson & Johnson

(Exact name of registrant as specified in its charter)


i New Jersey	i 1-3215	i 22-1024240
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

i One Johnson & Johnson Plaza, i New Brunswick, i New Jersey i 08933

(Address of Principal Executive Offices)

(Zip Code)

Registrant's telephone number, including area code:

i 732- i 524-0400

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

i ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17

CFR 240.14d-2(b))

i ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17

CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
i Common Stock, Par Value $1.00	i JNJ	i New York Stock Exchange
i 0.250% Notes Due January 2022	i JNJ22	i New York Stock Exchange
i 0.650% Notes Due May 2024	i JNJ24C	i New York Stock Exchange
i 5.50% Notes Due November 2024	i JNJ24BP	i New York Stock Exchange
i 1.150% Notes Due November 2028	i JNJ28	i New York Stock Exchange
i 1.650% Notes Due May 2035	i JNJ35	i New York Stock Exchange

Item 2.02 Results of Operations and Financial Condition

On April 20, 2021, Johnson & Johnson issued the attached press release announcing its sales and earnings for the first quarter ended April 4, 2021.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits.


Exhibit No.			Description of Exhibit
99.1			Press Release dated April 20, 2021 for the period ended April 4 , 202 1
99.2			Unaudited Comparative Supplementary Sales Data and Condensed Consolidated Statement of Earnings for the first q uarter
104			The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Johnson & Johnson

(Registrant)

Date:

April 20, 2021

By:

/s/ Robert J. Decker, Jr.

Robert J. Decker, Jr.
Controller
(Principal Accounting Officer)